News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Arcus Biosciences
< Previous
1
2
3
4
5
Next >
Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 12, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
November 18, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
October 30, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
October 30, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
October 28, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
October 19, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
October 09, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
October 06, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
September 24, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
September 08, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation
September 02, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
August 20, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
August 06, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
July 24, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer
July 10, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
June 10, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
June 01, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
May 27, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
May 09, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update
May 06, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
April 24, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting
April 23, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update
April 22, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
March 25, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
February 26, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Close